1. Home
  2. GSK vs SNPS Comparison

GSK vs SNPS Comparison

Compare GSK & SNPS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GSK
  • SNPS
  • Stock Information
  • Founded
  • GSK 1715
  • SNPS 1986
  • Country
  • GSK United Kingdom
  • SNPS United States
  • Employees
  • GSK N/A
  • SNPS N/A
  • Industry
  • GSK Biotechnology: Pharmaceutical Preparations
  • SNPS EDP Services
  • Sector
  • GSK Health Care
  • SNPS Technology
  • Exchange
  • GSK Nasdaq
  • SNPS Nasdaq
  • Market Cap
  • GSK 74.6B
  • SNPS 81.0B
  • IPO Year
  • GSK N/A
  • SNPS 1992
  • Fundamental
  • Price
  • GSK $38.77
  • SNPS $428.85
  • Analyst Decision
  • GSK Hold
  • SNPS Buy
  • Analyst Count
  • GSK 4
  • SNPS 12
  • Target Price
  • GSK $47.00
  • SNPS $629.83
  • AVG Volume (30 Days)
  • GSK 4.7M
  • SNPS 1.3M
  • Earning Date
  • GSK 04-30-2025
  • SNPS 05-21-2025
  • Dividend Yield
  • GSK 4.00%
  • SNPS N/A
  • EPS Growth
  • GSK N/A
  • SNPS 48.91
  • EPS
  • GSK 0.78
  • SNPS 13.51
  • Revenue
  • GSK $39,280,393,592.00
  • SNPS $6,071,762,000.00
  • Revenue This Year
  • GSK $7.60
  • SNPS $12.97
  • Revenue Next Year
  • GSK $5.24
  • SNPS $12.80
  • P/E Ratio
  • GSK $23.82
  • SNPS $31.74
  • Revenue Growth
  • GSK 3.46
  • SNPS 8.51
  • 52 Week Low
  • GSK $31.72
  • SNPS $423.08
  • 52 Week High
  • GSK $45.93
  • SNPS $624.80
  • Technical
  • Relative Strength Index (RSI)
  • GSK 53.04
  • SNPS 34.62
  • Support Level
  • GSK $37.76
  • SNPS $438.12
  • Resistance Level
  • GSK $38.98
  • SNPS $460.44
  • Average True Range (ATR)
  • GSK 0.53
  • SNPS 12.54
  • MACD
  • GSK -0.24
  • SNPS 1.25
  • Stochastic Oscillator
  • GSK 37.08
  • SNPS 14.02

About GSK GSK plc (Each representing two)

In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, antiviral, and vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.

About SNPS Synopsys Inc.

Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.

Share on Social Networks: